NDV-3, a Recombinant Alum-Adjuvanted Vaccine for Candida and Staphylococcus aureus is Safe and Immunogenic in Healthy Adults

Por Schmidt, Clint S., White, C. Jo, Ibrahim, Ashraf S., Filler, Scott G., Fu, Yue, Yeaman, Michael R., Edwards, John E., Hennessey, John P.
Publicado em 2012

Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins

Por Tussey, Lynda, Strout, Cynthia, Davis, Matthew, Johnson, Casey, Lucksinger, Gregg, Umlauf, Scott, Song, Langzhou, Liu, Ge, Abraham, Katalin, White, C. Jo
Publicado no Open Forum Infect Dis (2016)

Phase I/II Trial of the Anti-HIV Activity of Mifepristone in HIV-Infected Subjects ACTG 5200

Por Para, Michael F., Schouten, Jeff, Rosenkranz, Susan L., Yu, Song, Weiner, David, Tebas, Pablo, White, C. Jo, Reeds, Dominic, Lertora, Juan, Patterson, Kristine B., Daar, Eric S., Cavert, Wintson, Brizz, Barbara
Publicado em 2010

Immunotherapy Against HPV16/18 Generates Potent T(H)1 and Cytotoxic Cellular Immune Responses

Por Bagarazzi, Mark L., Yan, Jian, Morrow, Matthew P., Shen, Xuefei, Parker, R. Lamar, Lee, Jessica C., Giffear, Mary, Pankhong, Panyupa, Khan, Amir S., Broderick, Kate E., Knott, Christine, Lin, Feng, Boyer, Jean D., Draghia-Akli, Ruxandra, White, C. Jo, Kim, J. Joseph, Weiner, David B., Sardesai, Niranjan Y.
Publicado no Sci Transl Med (2012)